Risk of Relapse Found in Select Patients With NMOSD on Immunosuppressants
Patients with neuromyelitis optica spectrum disorder (NMOSD) that have an onset of the condition at a younger age, polysystem involvement in the first attack, and increased or unchanged titer of aquaporin-4 (AQP4-IgG) are most likely to experience relapse under treatment with immunosuppressants, a study found. The study suggested a higher efficacy treatment than immunosuppressants might…
